UPC Analytics
DEEN
Übersicht · Eingereicht:

UPC_APP_13099/2025

FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Prozessuale & UnteranträgeRücknahmeanträgeCourt of AppealApplication Rop 265Vergleich erfolgt: Nach PI
Parteien

Kläger

  • EOFLOW Co., Ltd.
Vertreter: Mirko Weinert (Hoyng ROKH Monegier)

Beklagte

  • Insulet Corporation
Vertreter: Marc Grunwald (Peterreins Schley)
Richter
  • Peter BlokLegally qualified judge and standing judge
Patente
  • EP 4 201 327
CPC-Codes: A61M5/1723, A61M5/1452, A61M5/158, A61B5/14865, A61M5/14244, F04B9/02, A61B5/14532, A61M2230/201, A61M2005/14506, A61M5/14248, B65D83/761, A61M5/3291

Sektor: Packaging & Conveying

Ausgang
Zurückgenommen
Eingereicht:
Erste Entscheidung: 3. Apr. 2025
Sprache:
Vergleich erfolgt: Nach PI

Court of Appeal (standing judge Blok) order permitting EOFlow Co., Ltd.'s withdrawal of its application for leave to appeal against a Milan Central Division cost order and declaring the leave-to-appeal proceedings closed. EOFlow had sought leave to appeal against the dismissal of its cost application following Insulet's failed provisional measures request. Both parties agreed to the withdrawal and neither sought a costs decision for the leave-to-appeal proceedings.